EYE Summary (August 2024): Incredibly Undervalued, page-15

Well I know when SGHT was going through it's high growth stage it was getting a valuation of over 50x sales! That would be over $5 for EYE with current fundamentals

Glaukos is actually pretty high still at 20x sales, and I don't think they'll ever record a profit lol.



EYE is now the highest growth stock in the MIGS space, and the closest to profitability as well, yet it is the most undervalued on a sales/MC basis. It also quite clearly has one of the best devices, this is easy enough to see with the rapid uptake, but it make intuitive sense as well due to all the unique patent protected and highly desirable features of this device.


I still do have confidence in the Aussie market to properly value these stocks, I've seen plenty of examples. Just tends to take more time, perhaps it's a blessing for anyone who still wants more shares!